Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Foscarbidopa

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 961Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Foscarbidopa, 1907685-81-7, Foscarbidopa [usan], 5nt8hca4oo, (2s)-2-hydrazinyl-3-[3-hydroxy-4-(phosphonooxy)phenyl]-, (2s)-2-hydrazinyl-3-(3-hydroxy-4-(phosphonooxy)phenyl)-2-methylpropanoic acid
    Molecular Formula
    C10H15N2O7P
    Molecular Weight
    306.21  g/mol
    InChI Key
    PQUZXFMHVSMUNG-JTQLQIEISA-N
    FDA UNII
    5NT8HCA4OO
    Foscarbidopa is under investigation in clinical trial NCT04379050 (Extension Study to Evaluate Safety and Tolerability of 24-hour Daily Exposure of Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Parkinson's Disease).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-2-hydrazinyl-3-(3-hydroxy-4-phosphonooxyphenyl)-2-methylpropanoic acid
    2.1.2 InChI
    InChI=1S/C10H15N2O7P/c1-10(12-11,9(14)15)5-6-2-3-8(7(13)4-6)19-20(16,17)18/h2-4,12-13H,5,11H2,1H3,(H,14,15)(H2,16,17,18)/t10-/m0/s1
    2.1.3 InChI Key
    PQUZXFMHVSMUNG-JTQLQIEISA-N
    2.1.4 Canonical SMILES
    CC(CC1=CC(=C(C=C1)OP(=O)(O)O)O)(C(=O)O)NN
    2.1.5 Isomeric SMILES
    C[C@](CC1=CC(=C(C=C1)OP(=O)(O)O)O)(C(=O)O)NN
    2.2 Other Identifiers
    2.2.1 UNII
    5NT8HCA4OO
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Foscarbidopa

    2. 1907685-81-7

    3. Foscarbidopa [usan]

    4. 5nt8hca4oo

    5. (2s)-2-hydrazinyl-3-[3-hydroxy-4-(phosphonooxy)phenyl]-

    6. (2s)-2-hydrazinyl-3-(3-hydroxy-4-(phosphonooxy)phenyl)-2-methylpropanoic Acid

    7. (2s)-2-hydrazinyl-3-[3-hydroxy-4-(phosphonooxy)phenyl]-2-methylpropanoic Acid

    8. Abbv-951 Carbidopa

    9. Unii-5nt8hca4oo

    10. Foscarbidopa [inn]

    11. Chembl4802240

    12. Schembl17693633

    13. Chebi:192511

    14. Who 11007

    15. Abbv-951 Component Foscarbidopa

    16. Hy-109131

    17. Cs-0086771

    18. (2s)-2-hydrazinyl-3-(3-hydroxy-4-phosphonooxyphenyl)-2-methylpropanoic Acid

    19. (alphas)-alpha-hydrazinyl-3-hydroxy-alpha-methyl-4-(phosphonooxy)benzenepropanoic Acid

    20. Benzenepropanoic Acid, Alpha-hydrazinyl-3-hydroxy-alpha-methyl-4-(phosphonooxy)-, (alphas)-

    21. (.alpha.s)-.alpha.-hydrazinyl-3-hydroxy-.alpha.-methyl-4-(phosphonooxy)benzenepropanoic Acid

    22. Benzenepropanoic Acid, .alpha.-hydrazinyl-3-hydroxy-.alpha.-methyl-4-(phosphonooxy)-, (.alpha.s)-

    2.4 Create Date
    2016-08-06
    3 Chemical and Physical Properties
    Molecular Weight 306.21 g/mol
    Molecular Formula C10H15N2O7P
    XLogP3-5.8
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count6
    Exact Mass306.06168782 g/mol
    Monoisotopic Mass306.06168782 g/mol
    Topological Polar Surface Area162 Ų
    Heavy Atom Count20
    Formal Charge0
    Complexity401
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1